Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

New treatment helps breast cancer patients keep their hair

Duration: 05:37s - Published: < > Embed
News video: New treatment helps breast cancer patients keep their hairA new treatment option using cold caps can help many breast cancer patients keep their hair during chemotherapy. CBS News' Barry Petersen and his wife, breast cancer survivor Mary Nell Wolff, join CBSN to discuss how they work.

0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

Genetic test could help fight secondary breast cancer

Genetic test could help fight secondary breast cancerThousands of breast cancer patients at risk of developing aggressive secondary tumours could benefit...
WorldNews - Front Page

Knitted Knockers are created to help breast-cancer patients

FREDERICKSBURG, Va. (AP) — As Suzy Woolam worked with breast-cancer patients, the one thing she...
Seattle Times - Front Page

Astra and Merck win speedy review for Lynparza in breast cancer

LONDON (Reuters) - U.S. regulators have granted a priority review to AstraZeneca's ovarian cancer...
Reuters - Health

Naturopathic Medicine Supports Breast Cancer Treatment and Prevention

WASHINGTON: For patients with breast cancer, naturopathic medicine can help optimize tolerance to...
newKerala.com - World

Study: Your hair dye may be increasing your risk of breast cancer

A new study suggests that women who frequently dye their hair are at a greater risk of getting breast...
USATODAY.com - Technology

Game-changing gene therapy to treat blood cancer approved by the FDA

The Food and Drug Administration on Wednesday approved a promising new treatment for a particularly...
Mashable - Internet

ANGLE PLC 's Parsortix liquid biopsy top in kidney cancer study

ANGLE PLC’s (LON:AGL,OTCQX: ANPCY) Parsortix system has outperformed comparable liquid biopsies in...
Proactive Investors - Business

US FDA Accepts Regulatory Submission for LYNPARZA® (olaparib) in Metastatic Breast Cancer and Grants Priority Review

US FDA Accepts Regulatory Submission for LYNPARZA® (olaparib) in Metastatic Breast Cancer and Grants Priority ReviewWILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside...
Business Wire - Press Releases

Breast cancer risk quantified based on rare variants and background risk

Rare variants combined with background genetic risk factors may account for many unexplained cases of...
Science Daily - Science

Gilead Gets FDA Approval for New Cancer Therapy

Gilead Sciences’ $11 billion bet on Kite Pharma is poised to pay off, with the approval of Kite’s...
Wall Street Journal - Business


You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+